United States - English - NLM (National Library of Medicine)

strides pharma science limited - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37, bicarbonate ion - unii:hn1zra3q20), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chlorate (unii: h35ks68ee7) (potassium cation - unii:295o53k152, chlorate ion - unii:08z8093742) - polyethylene glycol 3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults polyethylene glycol 3350 and electrolytes for oral solution, is contraindicated in the following conditions: -   gastrointestinal (gi) obstruction [see warnings and precautions (5.6)] -   bowel perforation [see warnings and precautions (5.6)] -   toxic colitis or toxic megacolon -   gastric retention -   ileus -   hypersensitivity to any component of polyethylene glycol 3350 and electrolytes for oral solution [see warnings and precautions (5.8)] animal reproduction studies have not been conducted with polyethylene glycol 3350 and electrolytes for oral solution. it is also not known whether polyethylene glycol 3350 and electrolytes for oral solution, can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. polyethylene glycol 3350 and electrolytes for oral solution, should be given to a pregnant woman only if clearl

United States - English - NLM (National Library of Medicine)

novel laboratories, inc. - polyethylene glycol 3350 (unii: g2m7p15e5p) (polyethylene glycol 3350 - unii:g2m7p15e5p), sodium sulfate anhydrous (unii: 36kcs0r750) (sodium sulfate anhydrous - unii:36kcs0r750), sodium bicarbonate (unii: 8mdf5v39qo) (sodium cation - unii:lyr4m0nh37), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152) - polyethylene glycol 3350 236 g in 274.31 g - peg-3350 and electrolytes for oral solution is indicated for bowel cleansing prior to colonoscopy and barium enema x-ray examination in adults. peg-3350 and electrolytes for oral solution is contraindicated in the following conditions: - gastrointestinal (gi) obstruction (5.6) - bowel perforation (5.6) - toxic colitis or toxic megacolon - gastric retention - ileus - hypersensitivity to components of peg-3350 and electrolytes for oral solution (5.8) animal reproduction studies have not been conducted with peg-3350 and electrolytes for oral solution. it is also not known whether peg-3350 and electrolytes for oral solution can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. peg-3350 and electrolytes for oral solution should be given to a pregnant woman only if clearly needed. it is not known whether this drug is excreted in human milk. because many drugs are excreted in human milk, caution should be exercised when peg-3350 and electrolytes for oral solution is administ

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 3.48 mg/ml; arginine 3.56 mg/ml; aspartic acid 2.45 mg/ml; calcium 0.005 meq/ml (electrolytes); chlorine 0.048 meq/ml (electrolytes); glucose 25%; glutamic acid 2.58 mg/ml; glycine 1.75 mg/ml; histidine 1.05 mg/ml; isoleucine 2.31 mg/ml; leucine 3.5 mg/ml; lysine 3.68 mg/ml (as lysine acetate with 0.0252meq/ml acetate ions); magnesium 0.005 meq/ml (electrolytes); methionine 0.6 mg/ml; phenylalanine 1.04 mg/ml; phosphorus 0.015 mmol/ml (electrolytes); potassium 0.033 meq/ml (electrolytes); proline 2.52 mg/ml; serine 1.86 mg/ml; sodium 0.04 meq/ml (electrolytes); threonine 1.4 mg/ml; tryptophan 0.7 mg/ml; tyrosine 0.94 mg/ml; valine 1.75 mg/ml - solution for infusion - 3.5 % - active: alanine 3.48 mg/ml arginine 3.56 mg/ml aspartic acid 2.45 mg/ml calcium 0.005 meq/ml (electrolytes) chlorine 0.048 meq/ml (electrolytes) glucose 25% glutamic acid 2.58 mg/ml glycine 1.75 mg/ml histidine 1.05 mg/ml isoleucine 2.31 mg/ml leucine 3.5 mg/ml lysine 3.68 mg/ml (as lysine acetate with 0.0252meq/ml acetate ions) magnesium 0.005 meq/ml (electrolytes) methionine 0.6 mg/ml phenylalanine 1.04 mg/ml phosphorus 0.015 mmol/ml (electrolytes) potassium 0.033 meq/ml (electrolytes) proline 2.52 mg/ml serine 1.86 mg/ml sodium 0.04 meq/ml (electrolytes) threonine 1.4 mg/ml tryptophan 0.7 mg/ml tyrosine 0.94 mg/ml valine 1.75 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 4.22 mg/ml; arginine 4.32 mg/ml; aspartic acid 2.98 mg/ml; calcium 0.005 meq/ml (electrolytes); chlorine 0.048 meq/ml (electrolytes); glucose 20%; glutamic acid 3.14 mg/ml; glycine 2.12 mg/ml; histidine 1.28 mg/ml; isoleucine 2.8 mg/ml; leucine 4.25 mg/ml; lysine 4.46 mg/ml (as lysine acetate. includes 0.0306meq/ml acetate ions); magnesium 0.005 meq/ml (electrolytes); methionine 0.73 mg/ml; phenylalanine 1.26 mg/ml; phosphorus 0.015 mmol/ml (electrolytes); potassium 0.033 meq/ml (electrolytes); proline 2.52 mg/ml; serine 2.25 mg/ml; sodium 0.04 meq/ml (electrolytes); threonine 1.7 mg/ml; tryptophan 0.85 mg/ml; tyrosine 1.15 mg/ml; valine 2.12 mg/ml - solution for infusion - 4.25 % - active: alanine 4.22 mg/ml arginine 4.32 mg/ml aspartic acid 2.98 mg/ml calcium 0.005 meq/ml (electrolytes) chlorine 0.048 meq/ml (electrolytes) glucose 20% glutamic acid 3.14 mg/ml glycine 2.12 mg/ml histidine 1.28 mg/ml isoleucine 2.8 mg/ml leucine 4.25 mg/ml lysine 4.46 mg/ml (as lysine acetate. includes 0.0306meq/ml acetate ions) magnesium 0.005 meq/ml (electrolytes) methionine 0.73 mg/ml phenylalanine 1.26 mg/ml phosphorus 0.015 mmol/ml (electrolytes) potassium 0.033 meq/ml (electrolytes) proline 2.52 mg/ml serine 2.25 mg/ml sodium 0.04 meq/ml (electrolytes) threonine 1.7 mg/ml tryptophan 0.85 mg/ml tyrosine 1.15 mg/ml valine 2.12 mg/ml

New Zealand - English - Medsafe (Medicines Safety Authority)

intermed medical ltd - alanine 4.22 mg/ml; arginine 4.32 mg/ml; aspartic acid 2.98 mg/ml; calcium 0.0306 meq/ml (electrolytes); chlorine 0.048 meq/ml (electrolytes); glucose 25%; glutamic acid 3.14 mg/ml; glycine 2.12 mg/ml; histidine 1.28 mg/ml; isoleucine 2.8 mg/ml; leucine 4.25 mg/ml; lysine 4.46 mg/ml (as lysine acetate. includes 0.0252meq/ml acetate ions); magnesium 0.005 meq/ml (electrolytes); methionine 0.73 mg/ml; phenylalanine 1.26 mg/ml; phosphorus 0.015 mmol/ml (electrolytes); potassium 0.033 meq/ml (electrolytes); proline 3.07 mg/ml; serine 2.25 mg/ml; sodium 0.04 meq/ml (electrolytes); threonine 1.7 mg/ml; tryptophan 0.85 mg/ml; tyrosine 1.15 mg/ml; valine 2.12 mg/ml - solution for infusion - 4.25 % - active: alanine 4.22 mg/ml arginine 4.32 mg/ml aspartic acid 2.98 mg/ml calcium 0.0306 meq/ml (electrolytes) chlorine 0.048 meq/ml (electrolytes) glucose 25% glutamic acid 3.14 mg/ml glycine 2.12 mg/ml histidine 1.28 mg/ml isoleucine 2.8 mg/ml leucine 4.25 mg/ml lysine 4.46 mg/ml (as lysine acetate. includes 0.0252meq/ml acetate ions) magnesium 0.005 meq/ml (electrolytes) methionine 0.73 mg/ml phenylalanine 1.26 mg/ml phosphorus 0.015 mmol/ml (electrolytes) potassium 0.033 meq/ml (electrolytes) proline 3.07 mg/ml serine 2.25 mg/ml sodium 0.04 meq/ml (electrolytes) threonine 1.7 mg/ml tryptophan 0.85 mg/ml tyrosine 1.15 mg/ml valine 2.12 mg/ml

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - alanine; arginine ; aspartic acid; glutamic acid ; glycine; histidine; isoleucine; leucine ; lysine acetate; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine; magnesium chloride hexahydrate; potassium chloride; sodium acetate trihydrate ; sodium glycerophophate hydrate; glucose monohydrate; calcium chloride dihydrate; olive oil, refined; soya bean oil, refined ph.eur - emulsion for infusion - 12g/l nitrogen 950 kcal/l wtih electrolytes - solutions for parenteral nutrition; combinations

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: glycerol; sodium hydroxide; ascorbyl palmitate; egg lecithin; sodium oleate; water for injections - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - soya oil; olive oil - injection, intravenous infusion - excipient ingredients: water for injections; egg lecithin; ascorbyl palmitate; sodium hydroxide; glycerol; sodium oleate - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: sodium hydroxide; ascorbyl palmitate; egg lecithin; water for injections; sodium oleate; glycerol - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - olive oil; soya oil - injection, intravenous infusion - excipient ingredients: sodium hydroxide; ascorbyl palmitate; egg lecithin; water for injections; glycerol; sodium oleate - parenteral nutrition for adults and children above 2 years of age when oral or enteral nutrition is impossible, insufficient or contraindicated.